Intramuscular Bumetanide and Furosemide in Congestive Heart Failure
- 12 November 1981
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 21 (11) , 673-679
- https://doi.org/10.1002/j.1552-4604.1981.tb05682.x
Abstract
Bumetanide is a potent loop diuretic that acts at the ascending loop of Henle and proximal renal tubule blocking sodium reabsorption. In a study of 20 patients with congestive heart failure, using the intramuscular route, 40 mg furosemide was compared with 1 mg bumetanide. Both diuretics induced prompt diuresis and solute loss of sodium, potassium, calcium, magnesium, and chloride. In the dosages used in this protocol, furosemide was somewhat more effective than bumetanide with respect to total urine volume and the amounts of solutes excreted into the urine, and acted more rapidly. No serious side effects were observed in either group.Keywords
This publication has 10 references indexed in Scilit:
- Bumetanide and frusemide: qualitative differences [proceedings]Published by Wiley ,1977
- Diuretic effect and metabolism of bumetanide in manClinical Pharmacology & Therapeutics, 1977
- Intramuscular Injection of DrugsNew England Journal of Medicine, 1976
- Renal Cortical Blood Redistribution after Bumetanide Related to Heterogenicity of Cortical Prostaglandin Metabolism in DogsActa Physiologica Scandinavica, 1976
- Bumetanide Induced Increase of Renal Blood Flow in Conscious Dogs and its Relation to Local Renal Hormones (PGE, Kallikrein and Renin)Acta Pharmacologica et Toxicologica, 1976
- Bumetanide in congestive heart failureCurrent Medical Research and Opinion, 1976
- Diuretic action of bumetanide in advanced chronic renal insufficiencyEuropean Journal of Clinical Pharmacology, 1976
- Bioavailability of DrugsNew England Journal of Medicine, 1974
- Bumetanide: Potent New "Loop" DiureticBMJ, 1972